Macro

Search catalysts, news stories, and pressures, or browse the trust-weighted news feed below.

Home tech energy finance healthcare defense industrial consumer communication utilities real estate raw materials

← back

healthcare · sector mood

2013

year mood +0.31 · -0.12 to +0.50 across 12 mo

Monthly mood

bearish −1 +1 bullish

month values ▾

Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
+0.30	+0.30	+0.40	+0.40	+0.40	-0.12	+0.40	+0.40	+0.40	-0.04	+0.40	+0.50

Sovaldi hep-C cure approved; blockbuster wave begins

How this mood is scored ▾

Each day the model reads that day's news for the sector and asks, as someone who owns assets or makes their living in it: how am I feeling this month, and why? The month's mood is that running answer, tied to the specific events driving it (the story shown above). It leans on trusted, higher-impact reporting, and on the prior month when a month is quiet, so one loud headline can't swing it. The read updates daily through the month; once a month ends, its mood is locked. This year is read live from the news the pipeline actually collected (hover a bar for its story count). · last computed Jul 11, 2026

Top healthcare stories of 2013

Jun

Supreme Court bans patenting of natural human genes ascopost.com →

The U.S. Supreme Court ruled that naturally occurring human genes, such as BRCA1 and BRCA2, cannot be patented, invalidating key patents held by Myriad Genetics. However, synthetic cDNA remains patent-eligible, preserving some intellectual property rights. The decision opens the market to competition, likely reducing genetic testing costs and accelerating innovation in personalized medicine.

Oct

HealthCare.gov crashes at launch, prompting tech surge cnn.com →

The federal Obamacare enrollment website, HealthCare.gov, suffered major technical failures at launch, hindering access for users despite plans to handle high traffic. The administration deployed a 'tech surge' led by Jeff Zients and Silicon Valley experts to fix issues, while contractors CGI, Serco, and Equifax face congressional scrutiny. Market implications include delayed enrollments and heightened political pressure, though the administration maintains the Affordable Care Act remains viable.